Brown et al. reported that glioma-derived CCL2/MCP-1 is ultimately responsible for the in vivo chemotaxis of adoptively transferred T-cells to glioma xenograft tumor sites (103), introducing promise for similar studies in glioma. Here, CCL2 is linked to central nervous system cancer.